Immunoglobulin Light Chains | List of Frontiers open access articles

Original Research

Published on 29 Dec 2022

Gut mycobiome dysbiosis contributes to the development of hypertension and its response to immunoglobulin light chains

in Microbial Immunology

Yeqing Zou
Anxing Ge
Brako Lydia
Chen Huang
Qianying Wang
Yanbo Yu

Frontiers in Immunology

doi 10.3389/fimmu.2022.1089295

3,736 views
15 citations

Original Research

Published on 22 Aug 2022

Identification of two rate-limiting steps in the degradation of partially folded immunoglobulin light chains

in Signaling

Melissa J. Mann
Ashley R. Flory
Christina Oikonomou
Candace A. Hayes
Chris Melendez-Suchi
Linda M. Hendershot

Frontiers in Cell and Developmental Biology

doi 10.3389/fcell.2022.924848

3,234 views
2 citations

Original Research

Published on 01 Apr 2021

Alteration of the Gut Microbiome in Chronic Kidney Disease Patients and Its Association With Serum Free Immunoglobulin Light Chains

in Mucosal Immunity

Fengping Liu
Xuefang Xu
Lin Chao
Ke Chen
Amo Shao
Danqin Sun
Yan Hong
Renjing Hu
Peng Jiang
Nan Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2021.609700

7,573 views
36 citations

Case Report

Published on 18 Sep 2025

Case Report: Safety and efficacy assessment of teclistamab in relapsed/refractory amyloidosis: a case study

in Cancer Immunity and Immunotherapy

Zhe Chen
Zhijian Zhang
Jieni Yu
Leihua Fu
Jiaping Fu
Weiying Feng

Frontiers in Oncology

doi 10.3389/fonc.2025.1664171

2,107 views

Case Report

Published on 16 Feb 2026

Pulmonary light chain deposition disease secondary to Sjögren disease: a case report

in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders

Xiaotong Xu
Lingjian Wang
Chunsheng Zhou
Lu Zhang
Ting Zhang
Min Peng
Rui’e Feng
Juhong Shi

Frontiers in Immunology

doi 10.3389/fimmu.2026.1747455

238 views

Review

Published on 24 Mar 2022

Multimodality Imaging in the Evaluation and Prognostication of Cardiac Amyloidosis

in Cardiovascular Imaging

Paul J. Scheel
Monica Mukherjee
Allison G. Hays
Joban Vaishnav

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.787618

5,978 views
17 citations

Review

Published on 30 Oct 2024

A review of recent clinical trials to evaluate disease-modifying therapies in the treatment of cardiac amyloidosis

in Gene and Cell Therapy

Sindhuja Senigarapu
James J. Driscoll

Frontiers in Medicine

doi 10.3389/fmed.2024.1477988

5,687 views
6 citations

Articles

Gut mycobiome dysbiosis contributes to the development of hypertension and its response to immunoglobulin light chains

Identification of two rate-limiting steps in the degradation of partially folded immunoglobulin light chains

Alteration of the Gut Microbiome in Chronic Kidney Disease Patients and Its Association With Serum Free Immunoglobulin Light Chains

Case Report: Safety and efficacy assessment of teclistamab in relapsed/refractory amyloidosis: a case study

Pulmonary light chain deposition disease secondary to Sjögren disease: a case report

Multimodality Imaging in the Evaluation and Prognostication of Cardiac Amyloidosis

A review of recent clinical trials to evaluate disease-modifying therapies in the treatment of cardiac amyloidosis